# DESCRIPTION

## BACKGROUND

- motivate need for new biomarkers and therapeutic markers for prostate cancer

## SUMMARY

- introduce genomic arrangement for diagnosing and prognosing prostate cancer
- describe methods for detecting ZBTB20/LSAMP genomic rearrangement
- outline compositions for diagnosing or prognosing prostate cancer
- summarize aspects of the invention

## DETAILED DESCRIPTION

- provide detailed explanation

### DEFINITIONS

- define terms related to ancestry
- define antibody and related terms
- define detecting and detection
- define therapeutically effective amount
- define gene expression profile
- define isolated polypeptide or nucleic acid
- define polypeptide probe and primer
- define variation and genomic rearrangement
- define PTEN gene
- describe PTEN deletion disparity across ethnic groups
- propose treatment selection method based on PTEN deletion
- list PI3K/PTEN/Akt/mTOR pathway inhibitors
- describe detecting ZBTB20/LSAMP genomic rearrangement
- describe detecting PTEN deletion
- outline chromosomal rearrangement detection methods
- describe measuring gene expression
- outline methods for determining gene fusion or mRNA/cDNA sequence presence
- define gene fusion detection methods
- describe immunoassay techniques for protein detection
- outline mass spectrometry methods for protein analysis
- describe sample preparation and collection
- discuss prostate cancer diagnosis and prognosis
- outline patient treatment options
- describe computer-implemented models for data analysis
- define polynucleotide probes
- describe composition for diagnosing prostate cancer
- specify primers for amplifying gene fusion
- describe oligonucleotide duplex
- outline kits for diagnosing prostate cancer
- describe antibodies that bind to chimeric ZBTB20/LSAMP fusion protein
- specify epitopes present in truncated LSAMP protein
- describe methods of making antibodies
- outline compositions comprising antibodies
- describe pharmaceutical compositions and administration

### Examples

- conduct comparative full genome analysis
- identify genes with somatic mutations
- stratify genetic alterations based on ethnicity
- validate PTEN deletions by FISH assay
- analyze genomic rearrangements of ZBTB20/LSAMP loci
- validate association of ZBTB20/LSAMP fusion transcript with AA ethnicity
- evaluate ZBTB20-LSAMP deletions in CaP tumors and cell lines

